Tag Archives: biosimilar
Time to switch? Switching from innovator rituximab to biosimilar CT-P10 is safe and efficacious
Rituximab is a monoclonal antibody that targets the CD20 protein that is found mainly on immune cells called B lymphocytes. By removing CD20-positive B lymphocytes from the peripheral blood and bone marrow, rituximab provides effective treatment for
Long-term safety and efficacy of rituximab biosimilar CT-P10 in rheumatoid arthritis
Rituximab is a monoclonal antibody used to treat certain cancers of the blood, as well as immune-mediated diseases such as rheumatoid arthritis. But while rituximab is effective, it is also expensive, which means that not everyone who
Are less expensive “biosimilar” drugs as effective at treating ankylosing spondylitis?
Clinical studies ask: “Are less expensive ‘biosimilar’ drugs as effective and safe as current drugs?”
Hope and concern
The ancient way of curing disease was the administration of natural products to the patient. The next step in drug discovery resulted from advances in chemistry. After isolation of natural active ingredients, synthesis in the laboratory of